Epstein-Barr virus antibodies could help differentiate MS from MOGAD and NMOSD. Discover how this biomarker may improve diagnosis. Read more.
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...
The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...
Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second ...
A single treatment of viral vector-delivered CAR-A construct in mice with existing plaque saturation cut the amount of amyloid plaques in half.
A new study analysing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Of the 373 specimens tested, 74 (20%) were positive for LASV antigen. Compared with qRT-PCR, antigen ...
These results imply that therapeutic strategies designed to inhibit T-cell receptor–driven recruitment based on targeting granule release or components of the lateral border recycling compartment will ...
This work introduces and describes a useful curation pipeline of antibody-antigen structures downloaded from the PDB database. The antibody-antigen structures are presented in a new database called ...
SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results